跳至主要内容
临床试验/NCT04776772
NCT04776772已完成不适用

Differential Health Effects on Inflammatory, Immunological and Stress Parameters in Professional Soccer Players and Sed-entary Individuals After Consuming a Synbiotic. A Triple Blind-ed, Randomized, Placebo-controlled Pilot Study

Catholic University of Murcia2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2019年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
27
试验地点
2
主要终点
Questionnarie about perceived depression

研究概览

简要总结

The main objective of this research was to carry out an experimental study, triple blind, on the possible immunophysiological effects of a nutritional supplement (Synbiotic, Gasteel Plus®, Heel España S.A.U.), containing a mixture of probiotic strains, such as Bifidobacterium lactis CBP-001010, Lactobacillus rhamnosus CNCM I-4036, Bifidobacterium longum ES1, as well as prebi-otic fructooligosaccharides, in both professional athletes and sedentary people. The effects on some inflammatory/immune (IL-1β, IL-10, and immunoglobulin A) and stress (epinephrine, nore-pinephrine, dopamine, serotonin, CRH, ACTH, and cortisol) biomarkers were evaluated, determined by flow cytometer and ELISA. The effects on metabolic profile and physical activity, as well as on various parameters that could affect physical and mental health, were also evaluated via the use of accelerometry and validated questionnaires.

详细描述

This investigation was a triple blinded, randomized, placebo-controlled pilot study designed to identify the possible differing effects of the synbiotic Gasteel Plus® supplementation.

The participants were professional soccer players of the Second Division B of the Spanish League and sedentary students of the same sex and age range. Both study groups were randomly divided into two groups: a control group administered with placebo, and an experimental group administered with the synbiotic. Each participant was evaluated at baseline, as well as after the intervention which lasted one month. Only in the athletes group did the synbiotic intervention clearly improve objective physical activ-ity and sleep quality, as well as perceived general health, stress, and anxiety levels.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Sedentary individuals: students with low levels of physical activity (≤ 150 minutes/week),
  • Athletes: semi professional soccer players

排除标准

  • Participants were prohibited from consuming probiotics, prebiotics or fermented products (yogurt or other foods)
  • Presenting injury or illness

结局指标

主要结局

Questionnarie about perceived depression

时间窗: One day after the ingestion of the synbiotic or placebo

Beck´s Depression Inventory: Scale from 0 to 63. Higher scores mean a worse outcome.

Determination of the adrenocorticotropic hormone (ACTH) (Blood sampling)

时间窗: One day after the ingestion of the synbiotic or placebo

Analyzed by competitive inhibition enzyme immunoassays (ELISA), using The Human ACTH (Adrenocorticotropic Hormone) ELISA Kit (Elabscience, USA). Measured in pg/ml.

Determination of the corticotropin-releasing hormone (CRH) (Blood sampling)

时间窗: One day after the ingestion of the synbiotic or placebo

Analyzed by competitive inhibition enzyme immunoassays (ELISA), using The Human Corticotropin Releasing Hormone (CRH) RD-CRH-Hu (Kelowna, BC, V1W 4V3, Canada) Measured in pg/ml.

Determination of the stress hormones serotonin (Blood sampling)

时间窗: One day after the ingestion of the synbiotic or placebo

Analyzed by competitive inhibition enzyme immunoassays (ELISA), using The General 5-Hydroxytryptamine (5-HT) RD-5-HT-Ge. Measured in ng/ml.

Determination of the anti-inflammatory cytokine IL-10 (Blood sampling)

时间窗: One day after the ingestion of the synbiotic or placebo

Using the LuminexTM 200 System instrument (Luminex Corporation, Texas, USA) using the ProcartaPlex TM Multiplex Immunoassay for analysis. Measured in pg/ml.

Determination of the stress hormones Cortisol (Blood sampling)

时间窗: One day after the ingestion of the synbiotic or placebo

Analyzed by competitive inhibition enzyme immunoassays (ELISA), using The DetectX Cortisol Immunoassay Kit. Measured in µg/dl.

Questionnarie about anxiety levels (personality)

时间窗: One day after the ingestion of the synbiotic or placebo

The Trait Anxiety Inventory (STAI): Scale from 0 to 60. Higher scores mean a worse outcome.

Objective determination of levels of physical activity, sedentary lifestyle and sleep quality: accelerometry

时间窗: During 7 days after the ingestion of the synbiotic or placebo

Participants wore the accelerometer held with an elastic band on the non-dominant wrist for 7 consecutive days and without interruption, except for those times of the day in which the correct operation of the device could be compromised (showers or any activity related to wa-ter). Subsequently, the files generated by the accelerometer were analyzed through a specific software called Actilife 6 (Actigraph, Pensacola, USA).

Questionnarie about general health.

时间窗: One day after the ingestion of the synbiotic or placebo

SF-36 Questionnaire: Scale from 0 to 100. Higher scores mean a better outcome.

Questionnarie about perceived stress

时间窗: One day after the ingestion of the synbiotic or placebo

The Perceived Stress Scale: Scale from 0 to 56. Higher scores mean a worse outcome.

Determination of the catecholamine epinephrine (Blood sampling)

时间窗: One day after the ingestion of the synbiotic or placebo

Analyzed by competitive inhibition enzyme immunoassays (ELISA), using The General Epinephrine (EPI) RD-EPI-Ge-96T. Measured in pg/ml.

Determination of the catecholamine norepinephrine (Blood sampling)

时间窗: One day after the ingestion of the synbiotic or placebo

Analyzed by competitive inhibition enzyme immunoassays (ELISA), using The General Noradrenaline (NE) RD-NE-Ge-96T. Measured in pg/ml.

Determination of glucose levels (metabolic profile)

时间窗: One day after the ingestion of the synbiotic or placebo

The determinations for obtaining the glycemic profile were carried out through standard techniques with the automatic analyzer of clinical chemistry BA 400 (BioSystems) in the SYNLAB laboratories (Diagnosticos Globales S.A.U., Badajoz, Spain). Measured in mg/dl

Questionnarie about anxiety levels (moment)

时间窗: One day after the ingestion of the synbiotic or placebo

The State Anxiety Inventory (STAI): Scale from 0 to 60. Higher scores mean a worse outcome.

Questionnarie about sleep quality

时间窗: One day after the ingestion of the synbiotic or placebo

Healthy Lifestyle and Personal Control Questionnaire: Scale from -1 to 10. Higher scores mean a better outcome.

Questionnarie about perceived fatigue

时间窗: One day after the ingestion of the synbiotic or placebo

Brief Fatigue Inventory: Scale from 0 to 40. Higher scores mean a worse outcome.

Determination of the pro-inflammatory cytokine IL-1β (Blood sampling)

时间窗: One day after the ingestion of the synbiotic or placebo

Using the LuminexTM 200 System instrument (Luminex Corporation, Texas, USA) using the ProcartaPlex TM Multiplex Immunoassay for analysis. Measured in pg/ml.

Determination of the catecholamine dopamine (Blood sampling)

时间窗: One day after the ingestion of the synbiotic or placebo

Analyzed by competitive inhibition enzyme immunoassays (ELISA), using The Dopamine Research Immunoassay Measured in ng/ml.

Determination of the immunoglobulin A (Saliva sampling)

时间窗: One day after the ingestion of the synbiotic or placebo

Analyzed by indirect enzyme immunoassay kit through the Salivary Secretory IgA Kit (Salimetrics LLC, USA). The procedures followed the instructions of the manufacturers, and the findings were measured using an ELISA auto analyzer to quantify color intensity (Sunrise, Tecan, Männendorf, Switzerland). Measured in µg/ml

Determination of total cholesterol levels (metabolic profile)

时间窗: One day after the ingestion of the synbiotic or placebo

The determinations for obtaining the lipid profile were carried out through standard techniques with the automatic analyzer of clinical chemistry BA 400 (BioSystems) in the SYNLAB laboratories (Diagnosticos Globales S.A.U., Badajoz, Spain). Measured in mg/dl

Determination of the triglycerides levels (metabolic profile)

时间窗: One day after the ingestion of the synbiotic or placebo

The determinations for obtaining the lipid profile were carried out through standard techniques with the automatic analyzer of clinical chemistry BA 400 (BioSystems) in the SYNLAB laboratories (Diagnosticos Globales S.A.U., Badajoz, Spain). Measured in mg/dl

次要结局

未报告次要终点

研究者

发起方
Catholic University of Murcia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Carmen Daniela Quero Calero

Professor, principal investigator

Catholic University of Murcia

研究点 (2)

Loading locations...

相似试验